Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 37

    1.

    Long-term outcome of stem cell therapy for acute myocardial infarction: right results, wrong reasons.

    Forrester JS, Makkar RR, Marbán E.

    J Am Coll Cardiol. 2009 Jun 16;53(24):2270-2. No abstract available. PMID: 19520250 [PubMed - indexed for MEDLINE]Related articles

    2.

    New paradigms of myocardial regeneration post-infarction: tissue preservation, cell environment, and pluripotent cell sources.

    Forrester JS, White AJ, Matsushita S, Chakravarty T, Makkar RR.

    JACC Cardiovasc Interv. 2009 Jan;2(1):1-8.PMID: 19463391 [PubMed - in process]Related articles

    3.

    Comparison of coronary artery bypass surgery and percutaneous drug-eluting stent implantation for treatment of left main coronary artery stenosis.

    White AJ, Kedia G, Mirocha JM, Lee MS, Forrester JS, Morales WC, Dohad S, Kar S, Czer LS, Fontana GP, Trento A, Shah PK, Makkar RR.

    JACC Cardiovasc Interv. 2008 Jun;1(3):236-45.PMID: 19463306 [PubMed - indexed for MEDLINE]Related articles

    4.

    Comparison of drug-eluting stents with bare metal stents in unselected patients with acute myocardial infarction.

    Kupferwasser LI, Amorn AM, Kapoor N, Lee MS, Kar S, Cercek B, Dohad S, Mirocha J, Forrester JS, Shah PK, Makkar RR.

    Catheter Cardiovasc Interv. 2007 Jul 1;70(1):1-8.PMID: 17580366 [PubMed - indexed for MEDLINE]Related articles

    5.

    Comparison of bypass surgery with drug-eluting stents for diabetic patients with multivessel disease.

    Lee MS, Jamal F, Kedia G, Chang G, Kapoor N, Forrester J, Czer L, Zimmer R, DeRobertis M, Trento A, Makkar RR.

    Int J Cardiol. 2007 Dec 15;123(1):34-42. Epub 2007 Feb 12.PMID: 17292983 [PubMed - indexed for MEDLINE]Related articles

    6.

    Bivalirudin in acute coronary syndromes and percutaneous coronary intervention.

    Lee MS, Makkar RR.

    Rev Cardiovasc Med. 2006;7 Suppl 3:S27-34. Review.PMID: 17224881 [PubMed - indexed for MEDLINE]Related articles

    7.

    Stent fracture associated with drug-eluting stents: clinical characteristics and implications.

    Lee MS, Jurewitz D, Aragon J, Forrester J, Makkar RR, Kar S.

    Catheter Cardiovasc Interv. 2007 Feb 15;69(3):387-94.PMID: 17195203 [PubMed - indexed for MEDLINE]Related articles

    8.

    Myocardial regeneration by stem cells: seeing the unseeable.

    Forrester JS, Shah PK, Makkar RR.

    J Am Coll Cardiol. 2006 Oct 17;48(8):1722-4. Epub 2006 Sep 11. Review. No abstract available. PMID: 17045911 [PubMed - indexed for MEDLINE]Related articles

    9.

    Percutaneous coronary intervention in unprotected left main disease: a status report.

    Kupferwasser LI, Lee MS, Schapira JN, Makkar RR.

    Minerva Cardioangiol. 2006 Oct;54(5):633-41. Review.PMID: 17019399 [PubMed - indexed for MEDLINE]Related articles

    10.

    The effect of granulocyte colony stimulating factor on regional and global myocardial function in the porcine infarct model.

    Lee SS, Naqvi TZ, Forrester J, Cattley R, Shah A, Frantzen M, Miyamoto T, Kaufman S, Price MJ, Lill M, Makkar RR.

    Int J Cardiol. 2007 Mar 20;116(2):225-30. Epub 2006 Aug 4.PMID: 16889856 [PubMed - indexed for MEDLINE]Related articles

    11.

    The Janus face of drug-eluting stents.

    Forrester JS, Lee MS, Kapoor N, Makkar RR.

    J Am Coll Cardiol. 2006 Jul 18;48(2):375-6. Epub 2006 Jun 22. No abstract available. PMID: 16843189 [PubMed - indexed for MEDLINE]Related articles

    12.

    Percutaneous left ventricular support devices.

    Lee MS, Makkar RR.

    Cardiol Clin. 2006 May;24(2):265-75, vii. Review.PMID: 16781943 [PubMed - indexed for MEDLINE]Related articles

    13.

    Coronary perforation after percutaneous coronary intervention successfully treated with local thrombin injection.

    Jamali AH, Lee MS, Makkar RR.

    J Invasive Cardiol. 2006 Apr;18(4):E143-5. No abstract available. PMID: 16723750 [PubMed - indexed for MEDLINE]Related articles

    14.

    Comparison of coronary artery bypass surgery with percutaneous coronary intervention with drug-eluting stents for unprotected left main coronary artery disease.

    Lee MS, Kapoor N, Jamal F, Czer L, Aragon J, Forrester J, Kar S, Dohad S, Kass R, Eigler N, Trento A, Shah PK, Makkar RR.

    J Am Coll Cardiol. 2006 Feb 21;47(4):864-70. Epub 2006 Jan 6.PMID: 16487857 [PubMed - indexed for MEDLINE]Related articles

    15.

    Coronary sinus is dilated and outwardly displaced in patients with mitral regurgitation: quantitative angiographic analysis.

    Lee MS, Shah AP, Dang N, Berman D, Forrester J, Shah PK, Aragon J, Jamal F, Makkar RR.

    Catheter Cardiovasc Interv. 2006 Mar;67(3):490-4.PMID: 16475163 [PubMed - indexed for MEDLINE]Related articles

    16.

    Intramyocardial injection of allogenic bone marrow-derived mesenchymal stem cells without immunosuppression preserves cardiac function in a porcine model of myocardial infarction.

    Makkar RR, Price MJ, Lill M, Frantzen M, Takizawa K, Kleisli T, Zheng J, Kar S, McClelan R, Miyamota T, Bick-Forrester J, Fishbein MC, Shah PK, Forrester JS, Sharifi B, Chen PS, Qayyum M.

    J Cardiovasc Pharmacol Ther. 2005 Dec;10(4):225-33.PMID: 16382259 [PubMed - indexed for MEDLINE]Related articles

    17.

    Drug-eluting stenting is superior to bare metal stenting in saphenous vein grafts.

    Lee MS, Shah AP, Aragon J, Jamali A, Dohad S, Kar S, Makkar RR.

    Catheter Cardiovasc Interv. 2005 Dec;66(4):507-11.PMID: 16270361 [PubMed - indexed for MEDLINE]Related articles

    18.

    Intravenous mesenchymal stem cell therapy early after reperfused acute myocardial infarction improves left ventricular function and alters electrophysiologic properties.

    Price MJ, Chou CC, Frantzen M, Miyamoto T, Kar S, Lee S, Shah PK, Martin BJ, Lill M, Forrester JS, Chen PS, Makkar RR.

    Int J Cardiol. 2006 Aug 10;111(2):231-9. Epub 2005 Oct 24.PMID: 16246440 [PubMed - indexed for MEDLINE]Related articles

    19.

    Percutaneous left ventricular assist device: "TandemHeart" for high-risk coronary intervention.

    Aragon J, Lee MS, Kar S, Makkar RR.

    Catheter Cardiovasc Interv. 2005 Jul;65(3):346-52.PMID: 15945107 [PubMed - indexed for MEDLINE]Related articles

    20.

    Stem-cell repair of infarcted myocardium: ready for clinical application?

    Lee S, Bick-Forrester J, Makkar RR, Forrester JS.

    Am Heart Hosp J. 2004 Spring;2(2):100-6. Review.PMID: 15604853 [PubMed - indexed for MEDLINE]Related articles

    21.

    AngioJet thrombectomy.

    Lee MS, Singh V, Wilentz JR, Makkar RR.

    J Invasive Cardiol. 2004 Oct;16(10):587-91. Review.PMID: 15505358 [PubMed - indexed for MEDLINE]Related articles

    22.

    Partial restoration of myocardial function and perfusion by cell therapy following myocardial infarction.

    Bick-Forrester J, Lee MS, Makkar RR, Forrester JS.

    Curr Opin Cardiol. 2004 Nov;19(6):631-7. Review.PMID: 15502511 [PubMed - indexed for MEDLINE]Related articles

    23.

    Percutaneous stent-mounted valve for treatment of aortic or pulmonary valve disease.

    Webb JG, Munt B, Makkar RR, Naqvi TZ, Dang N.

    Catheter Cardiovasc Interv. 2004 Sep;63(1):89-93.PMID: 15343576 [PubMed - indexed for MEDLINE]Related articles

    24.

    Hybrid revascularization using percutaneous coronary intervention and robotically assisted minimally invasive direct coronary artery bypass surgery.

    Lee MS, Wilentz JR, Makkar RR, Singh V, Nero T, Swistel D, Belsey SJ, Simon C, Rametta S, DeRose J.

    J Invasive Cardiol. 2004 Aug;16(8):419-25.PMID: 15282418 [PubMed - indexed for MEDLINE]Related articles

    25.
    26.

    Stem cell transplantation in myocardial infarction.

    Lee MS, Lill M, Makkar RR.

    Rev Cardiovasc Med. 2004 Spring;5(2):82-98. Review.PMID: 15184842 [PubMed - indexed for MEDLINE]Related articles

    27.

    Treatment of coronary aneurysm in acute myocardial infarction with AngioJet thrombectomy and JoStent coronary stent graft.

    Lee MS, Nero T, Makkar RR, Wilentz JR.

    J Invasive Cardiol. 2004 May;16(5):294-6.PMID: 15152122 [PubMed - indexed for MEDLINE]Related articles

    28.

    Stem-cell transplantation in myocardial infarction: a status report.

    Lee MS, Makkar RR.

    Ann Intern Med. 2004 May 4;140(9):729-37. Review.PMID: 15126257 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    Stem cell therapy for myocardial repair: is it arrhythmogenic?

    Makkar RR, Lill M, Chen PS.

    J Am Coll Cardiol. 2003 Dec 17;42(12):2070-2. No abstract available. PMID: 14680728 [PubMed - indexed for MEDLINE]Related articles

    30.

    Mending the broken heart.

    Forrester JS, Price M, Makkar RR.

    Clin Cardiol. 2003 Oct;26(10):449-50. No abstract available. PMID: 14579913 [PubMed - indexed for MEDLINE]Related articles

    31.

    Stem cell repair of infarcted myocardium: an overview for clinicians.

    Forrester JS, Price MJ, Makkar RR.

    Circulation. 2003 Sep 2;108(9):1139-45. Review. No abstract available. PMID: 12952828 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    Effects of clopidogrel, aspirin and combined therapy in a porcine ex vivo model of high-shear induced stent thrombosis.

    Makkar RR, Eigler NL, Kaul S, Frimerman A, Nakamura M, Shah PK, Forrester JS, Herbert JM, Litvack F.

    Eur Heart J. 1998 Oct;19(10):1538-46.PMID: 9820993 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    Effects of GP IIb/IIIa receptor monoclonal antibody (7E3), heparin, and aspirin in an ex vivo canine arteriovenous shunt model of stent thrombosis.

    Makkar RR, Litvack F, Eigler NL, Nakamura M, Ivey PA, Forrester JS, Shah PK, Jordan RE, Kaul S.

    Circulation. 1997 Feb 18;95(4):1015-21.PMID: 9054765 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    Inhibition of acute stent thrombosis under high-shear flow conditions by a nitric oxide donor, DMHD/NO. An ex vivo porcine arteriovenous shunt study.

    Kaul S, Makkar RR, Nakamura M, Litvack FI, Shah PK, Forrester JS, Hutsell TC, Eigler NL.

    Circulation. 1996 Nov 1;94(9):2228-34.PMID: 8901676 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Prevention of Restenosis by Local Drug Delivery.

    Makkar RR, Eigler N, Litvack F, Forrester JS.

    J Cardiovasc Pharmacol Ther. 1996 Apr;1(2):177-188.PMID: 10684415 [PubMed - as supplied by publisher]Related articles

    36.

    Treatment of vascular disease with local drug delivery systems.

    Makkar RR, Litvack F, Eigler N, Forrester JS.

    Cardiologia. 1995 Sep;40(9):651-7. Review. No abstract available. PMID: 8542617 [PubMed - indexed for MEDLINE]Related articles

    37.

    Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs.

    Makkar RR, Fromm BS, Steinman RT, Meissner MD, Lehmann MH.

    JAMA. 1993 Dec 1;270(21):2590-7.PMID: 8230644 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...